Transplanted dopaminergic neurons develop PD pathologic changes: a second case report
- PMID: 19006193
- DOI: 10.1002/mds.22369
Transplanted dopaminergic neurons develop PD pathologic changes: a second case report
Abstract
This report describes pathological changes within the grafted neurons of another patient with Parkinson's disease (PD) who died 14 years posttransplantation. Although numerous healthy appearing grafted neurons were present at this long-term time point, some displayed Lewy bodies as evidenced by alpha-synuclein, ubiquitin, and thioflavin-S staining. Additionally, there was a general loss of dopamine transporter-immunoreactivity in grafted neurons. Some grafted cell displayed a loss of tyrosine hydroxylase. These data support the emerging concept that PD-like pathology is seen in young grafted neurons when they survive long term.
(c) 2008 Movement Disorder Society.
Similar articles
-
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?Neurobiol Dis. 2007 Jan;25(1):134-49. doi: 10.1016/j.nbd.2006.08.021. Epub 2006 Oct 18. Neurobiol Dis. 2007. PMID: 17055279
-
Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.J Comp Neurol. 2004 May 17;473(1):97-106. doi: 10.1002/cne.20098. J Comp Neurol. 2004. PMID: 15067721
-
The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease.Prog Neurobiol. 2005 Sep-Oct;77(1-2):128-38. doi: 10.1016/j.pneurobio.2005.09.001. Epub 2005 Oct 21. Prog Neurobiol. 2005. PMID: 16243425 Review.
-
Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.Neurochem Int. 2008 Jun;52(7):1332-42. doi: 10.1016/j.neuint.2008.02.003. Epub 2008 Mar 10. Neurochem Int. 2008. PMID: 18372079
-
Neuronal cell replacement in Parkinson's disease.J Intern Med. 2009 Oct;266(4):358-71. doi: 10.1111/j.1365-2796.2009.02155.x. J Intern Med. 2009. PMID: 19765180 Review.
Cited by
-
Could α-synuclein amyloid-like aggregates trigger a prionic neuronal invasion?Biomed Res Int. 2015;2015:172018. doi: 10.1155/2015/172018. Epub 2015 Mar 19. Biomed Res Int. 2015. PMID: 25866763 Free PMC article. Review.
-
Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.Science. 2012 Nov 16;338(6109):949-53. doi: 10.1126/science.1227157. Science. 2012. PMID: 23161999 Free PMC article.
-
Prion-like mechanisms in neurodegenerative diseases.Nat Rev Neurosci. 2010 Mar;11(3):155-9. doi: 10.1038/nrn2786. Epub 2009 Dec 23. Nat Rev Neurosci. 2010. PMID: 20029438 Free PMC article. Review.
-
Cell therapeutics in Parkinson's disease.Neurotherapeutics. 2011 Oct;8(4):539-48. doi: 10.1007/s13311-011-0069-6. Neurotherapeutics. 2011. PMID: 21901584 Free PMC article. Review.
-
Transmission of α-synuclein seeds in neurodegenerative disease: recent developments.Lab Invest. 2019 Jul;99(7):971-981. doi: 10.1038/s41374-019-0195-z. Epub 2019 Feb 13. Lab Invest. 2019. PMID: 30760864 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical